Helen Kales
Cited by
Cited by
Dementia prevention, intervention, and care
G Livingston, A Sommerlad, V Orgeta, SG Costafreda, J Huntley, D Ames, ...
The Lancet 390 (10113), 2673-2734, 2017
Assessment and management of behavioral and psychological symptoms of dementia
HC Kales, LN Gitlin, CG Lyketsos
Bmj 350, 2015
Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm
DT Maust, HM Kim, LS Seyfried, C Chiang, J Kavanagh, LS Schneider, ...
JAMA psychiatry 72 (5), 438-445, 2015
Nonpharmacologic management of behavioral symptoms in dementia
LN Gitlin, HC Kales, CG Lyketsos
Jama 308 (19), 2020-2029, 2012
Risk of mortality among individual antipsychotics in patients with dementia
HC Kales, HM Kim, K Zivin, M Valenstein, LS Seyfried, C Chiang, ...
American Journal of Psychiatry 169 (1), 71-79, 2012
Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications
HC Kales, M Valenstein, HM Kim, JF McCarthy, D Ganoczy, ...
American Journal of Psychiatry 164 (10), 1568-1576, 2007
Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel
HC Kales, LN Gitlin, CG Lyketsos, ...
Journal of the American Geriatrics Society 62 (4), 762-769, 2014
Benzodiazepine use among depressed patients treated in mental health settings
M Valenstein, KK Taylor, K Austin, HC Kales, JF McCarthy, FC Blow
American Journal of Psychiatry 161 (4), 654-661, 2004
Trends in antipsychotic use in dementia 1999-2007
HC Kales, K Zivin, HM Kim, M Valenstein, C Chiang, RV Ignacio, ...
Archives of general psychiatry 68 (2), 190-197, 2011
Cerebrovascular disease and late-life depression
HC Kales, DF Maixner, AM Mellow
The American Journal of Geriatric Psychiatry 13 (2), 88-98, 2005
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
G Livingston, J Huntley, A Sommerlad, D Ames, C Ballard, S Banerjee, ...
The Lancet 396 (10248), 413-446, 2020
Detroit Expert Panel on Assessment and Management of Neuropsychiatric Symptoms of Dementia. Management of neuropsychiatric symptoms of dementia in clinical settings …
HC Kales, LN Gitlin, CG Lyketsos
J Am Geriatr Soc 62 (4), 762-769, 2014
Rates of clinical depression diagnosis, functional impairment, and nursing home placement in coexisting dementia and depression
HC Kales, P Chen, FC Blow, DE Welsh, AM Mellow
The American Journal of Geriatric Psychiatry 13 (6), 441-449, 2005
Association of antipsychotic use with mortality risk in patients with Parkinson disease
D Weintraub, C Chiang, HM Kim, J Wilkinson, C Marras, B Stanislawski, ...
JAMA neurology 73 (5), 535-541, 2016
Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg
K Zivin, PN Pfeiffer, ASB Bohnert, D Ganoczy, FC Blow, BK Nallamothu, ...
American Journal of Psychiatry 170 (6), 642-650, 2013
Patterns and trends in antipsychotic prescribing for Parkinson disease psychosis
D Weintraub, P Chen, RV Ignacio, E Mamikonyan, HC Kales
Archives of neurology 68 (7), 899-904, 2011
Adherence to depression treatment in older adults
K Zivin, HC Kales
Drugs & aging 25 (7), 559-571, 2008
Predictors of suicide in patients with dementia
LS Seyfried, HC Kales, RV Ignacio, Y Conwell, M Valenstein
Alzheimer's & dementia 7 (6), 567-573, 2011
Combined electroconvulsive therapy and clozapine in treatment-resistant schizophrenia.
HC Kales, JR Dequardo, R Tandon
Progress in neuro-psychopharmacology & biological psychiatry, 1999
Health care utilization by older patients with coexisting dementia and depression
HC Kales, FC Blow, LA Copeland, RC Bingham, EE Kammerer, ...
American Journal of Psychiatry 156 (4), 550-556, 1999
The system can't perform the operation now. Try again later.
Articles 1–20